OTC:CBIA

Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study

LOS ANGELES, Dec. 19, 2014 /PRNewswire/ -- Canopus BioPharma Inc. (OTC Pink: CBIA) today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition. Laboratories at the Texas Biomedical Research Institute in San Antonio Texas ...

2014-12-19 22:00 2600